nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—Gemcitabine—pancreatic cancer	0.348	1	CrCtD
Zalcitabine—SLC29A1—pancreatic cancer	0.203	1	CbGaD
Zalcitabine—Lamivudine—Gemcitabine—pancreatic cancer	0.103	0.558	CrCrCtD
Zalcitabine—SLC29A2—Gemcitabine—pancreatic cancer	0.0496	0.246	CbGbCtD
Zalcitabine—Cytarabine—Gemcitabine—pancreatic cancer	0.0429	0.232	CrCrCtD
Zalcitabine—Decitabine—Gemcitabine—pancreatic cancer	0.0388	0.21	CrCrCtD
Zalcitabine—SLC29A1—Gemcitabine—pancreatic cancer	0.0285	0.141	CbGbCtD
Zalcitabine—DCK—Gemcitabine—pancreatic cancer	0.0264	0.131	CbGbCtD
Zalcitabine—SLC29A1—Fluorouracil—pancreatic cancer	0.0244	0.121	CbGbCtD
Zalcitabine—SLC22A7—Fluorouracil—pancreatic cancer	0.00916	0.0454	CbGbCtD
Zalcitabine—SLC22A7—Docetaxel—pancreatic cancer	0.00699	0.0347	CbGbCtD
Zalcitabine—CYP3A7—Tamoxifen—pancreatic cancer	0.00482	0.0239	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.00482	0.0239	CbGbCtD
Zalcitabine—SLC29A2—Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane—SLC29A1—pancreatic cancer	0.00392	0.35	CbGpPWpGaD
Zalcitabine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0037	0.0184	CbGbCtD
Zalcitabine—CYP3A7—Irinotecan—pancreatic cancer	0.0037	0.0184	CbGbCtD
Zalcitabine—CYP3A5—Tamoxifen—pancreatic cancer	0.00362	0.0179	CbGbCtD
Zalcitabine—CYP3A5—Erlotinib—pancreatic cancer	0.00308	0.0153	CbGbCtD
Zalcitabine—CYP3A5—Irinotecan—pancreatic cancer	0.00278	0.0138	CbGbCtD
Zalcitabine—CYP3A7—Docetaxel—pancreatic cancer	0.00271	0.0135	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.00271	0.0135	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0027	0.0134	CbGbCtD
Zalcitabine—CYP3A7—Sunitinib—pancreatic cancer	0.0027	0.0134	CbGbCtD
Zalcitabine—CYP2C9—Tamoxifen—pancreatic cancer	0.00243	0.012	CbGbCtD
Zalcitabine—CYP2D6—Tamoxifen—pancreatic cancer	0.00222	0.011	CbGbCtD
Zalcitabine—CYP3A5—Docetaxel—pancreatic cancer	0.00204	0.0101	CbGbCtD
Zalcitabine—CYP3A5—Sunitinib—pancreatic cancer	0.00203	0.0101	CbGbCtD
Zalcitabine—CYP2D6—Erlotinib—pancreatic cancer	0.00189	0.00936	CbGbCtD
Zalcitabine—CYP2C9—Fluorouracil—pancreatic cancer	0.00179	0.00887	CbGbCtD
Zalcitabine—CYP3A4—Tamoxifen—pancreatic cancer	0.00141	0.007	CbGbCtD
Zalcitabine—CYP3A4—Erlotinib—pancreatic cancer	0.0012	0.00595	CbGbCtD
Zalcitabine—CYP3A4—Irinotecan—pancreatic cancer	0.00108	0.00537	CbGbCtD
Zalcitabine—Didanosine—SLC29A1—pancreatic cancer	0.00104	0.545	CrCbGaD
Zalcitabine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.00101	0.0903	CbGpPWpGaD
Zalcitabine—DCK—Pyrimidine salvage reactions—TYMP—pancreatic cancer	0.000939	0.0837	CbGpPWpGaD
Zalcitabine—CYP2D6—Doxorubicin—pancreatic cancer	0.000931	0.00462	CbGbCtD
Zalcitabine—CYP3A4—Docetaxel—pancreatic cancer	0.000794	0.00394	CbGbCtD
Zalcitabine—CYP3A4—Sunitinib—pancreatic cancer	0.00079	0.00392	CbGbCtD
Zalcitabine—CYP3A4—Doxorubicin—pancreatic cancer	0.000592	0.00294	CbGbCtD
Zalcitabine—DCK—Topotecan—Irinotecan—pancreatic cancer	0.000479	0.568	CbGdCrCtD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.000448	0.0399	CbGpPWpGaD
Zalcitabine—DCK—Pyrimidine metabolism—TYMP—pancreatic cancer	0.000428	0.0382	CbGpPWpGaD
Zalcitabine—Gemcitabine—SLC29A1—pancreatic cancer	0.000425	0.223	CrCbGaD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000395	0.0352	CbGpPWpGaD
Zalcitabine—DCK—Pyrimidine metabolism—DPYD—pancreatic cancer	0.00034	0.0303	CbGpPWpGaD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000313	0.0279	CbGpPWpGaD
Zalcitabine—Cytarabine—SLC29A1—pancreatic cancer	0.00029	0.152	CrCbGaD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000225	0.0201	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000217	0.0194	CbGpPWpGaD
Zalcitabine—DCK—Pyrimidine metabolism—TYMS—pancreatic cancer	0.000194	0.0173	CbGpPWpGaD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000178	0.0159	CbGpPWpGaD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000178	0.0159	CbGpPWpGaD
Zalcitabine—DCK—Nucleotide metabolism—TYMP—pancreatic cancer	0.000167	0.0149	CbGpPWpGaD
Zalcitabine—Gemcitabine—TYMS—pancreatic cancer	0.000152	0.0794	CrCbGaD
Zalcitabine—DCK—Clomifene—Tamoxifen—pancreatic cancer	0.000148	0.175	CbGdCrCtD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000136	0.0121	CbGpPWpGaD
Zalcitabine—DCK—Nucleotide metabolism—DPYD—pancreatic cancer	0.000132	0.0118	CbGpPWpGaD
Zalcitabine—DCK—Doxorubicin—Epirubicin—pancreatic cancer	0.000113	0.134	CbGdCrCtD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00011	0.00986	CbGpPWpGaD
Zalcitabine—DCK—Epirubicin—Doxorubicin—pancreatic cancer	0.000104	0.124	CbGdCrCtD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000102	0.00906	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	9.4e-05	0.00838	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	8.59e-05	0.00766	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	8.21e-05	0.00733	CbGpPWpGaD
Zalcitabine—DCK—Nucleotide metabolism—TYMS—pancreatic cancer	7.54e-05	0.00672	CbGpPWpGaD
Zalcitabine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	7.14e-05	0.00637	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	6.91e-05	0.00616	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	6.02e-05	0.00537	CbGpPWpGaD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—pancreatic cancer	5.91e-05	0.00527	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	5.69e-05	0.00508	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	5.35e-05	0.00478	CbGpPWpGaD
Zalcitabine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	5.01e-05	0.00447	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	4.68e-05	0.00418	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	4.36e-05	0.00389	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.17e-05	0.00372	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	3.76e-05	0.00335	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	3.48e-05	0.0031	CbGpPWpGaD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—TP53—pancreatic cancer	3.37e-05	0.00301	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	3.24e-05	0.00289	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	3.06e-05	0.00273	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.89e-05	0.00258	CbGpPWpGaD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	2.79e-05	0.00249	CbGpPWpGaD
Zalcitabine—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	2.76e-05	0.00246	CbGpPWpGaD
Zalcitabine—Decreased appetite—Fluorouracil—pancreatic cancer	2.39e-05	0.000494	CcSEcCtD
Zalcitabine—Mood swings—Doxorubicin—pancreatic cancer	2.39e-05	0.000493	CcSEcCtD
Zalcitabine—Diarrhoea—Sunitinib—pancreatic cancer	2.39e-05	0.000493	CcSEcCtD
Zalcitabine—Dysgeusia—Docetaxel—pancreatic cancer	2.38e-05	0.000492	CcSEcCtD
Zalcitabine—Abdominal distension—Epirubicin—pancreatic cancer	2.37e-05	0.00049	CcSEcCtD
Zalcitabine—Ataxia—Doxorubicin—pancreatic cancer	2.37e-05	0.000489	CcSEcCtD
Zalcitabine—Feeling abnormal—Irinotecan—pancreatic cancer	2.37e-05	0.000489	CcSEcCtD
Zalcitabine—Blood creatinine increased—Doxorubicin—pancreatic cancer	2.36e-05	0.000488	CcSEcCtD
Zalcitabine—Dysphagia—Epirubicin—pancreatic cancer	2.35e-05	0.000486	CcSEcCtD
Zalcitabine—Back pain—Docetaxel—pancreatic cancer	2.35e-05	0.000486	CcSEcCtD
Zalcitabine—Pain—Fluorouracil—pancreatic cancer	2.35e-05	0.000486	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Irinotecan—pancreatic cancer	2.35e-05	0.000485	CcSEcCtD
Zalcitabine—Muscle spasms—Docetaxel—pancreatic cancer	2.34e-05	0.000483	CcSEcCtD
Zalcitabine—Eosinophilia—Epirubicin—pancreatic cancer	2.33e-05	0.000481	CcSEcCtD
Zalcitabine—Dry skin—Doxorubicin—pancreatic cancer	2.31e-05	0.000477	CcSEcCtD
Zalcitabine—Pancreatitis—Epirubicin—pancreatic cancer	2.31e-05	0.000477	CcSEcCtD
Zalcitabine—Dizziness—Sunitinib—pancreatic cancer	2.31e-05	0.000476	CcSEcCtD
Zalcitabine—Feeling abnormal—Gemcitabine—pancreatic cancer	2.3e-05	0.000476	CcSEcCtD
Zalcitabine—Abdominal pain upper—Doxorubicin—pancreatic cancer	2.3e-05	0.000475	CcSEcCtD
Zalcitabine—Hypokalaemia—Doxorubicin—pancreatic cancer	2.29e-05	0.000474	CcSEcCtD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	2.29e-05	0.00204	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	2.28e-05	0.00203	CbGpPWpGaD
Zalcitabine—Body temperature increased—Irinotecan—pancreatic cancer	2.27e-05	0.000469	CcSEcCtD
Zalcitabine—Abdominal pain—Irinotecan—pancreatic cancer	2.27e-05	0.000469	CcSEcCtD
Zalcitabine—Feeling abnormal—Fluorouracil—pancreatic cancer	2.27e-05	0.000468	CcSEcCtD
Zalcitabine—Nasopharyngitis—Doxorubicin—pancreatic cancer	2.25e-05	0.000465	CcSEcCtD
Zalcitabine—Anaemia—Docetaxel—pancreatic cancer	2.25e-05	0.000464	CcSEcCtD
Zalcitabine—Gastritis—Doxorubicin—pancreatic cancer	2.23e-05	0.000461	CcSEcCtD
Zalcitabine—Muscular weakness—Doxorubicin—pancreatic cancer	2.22e-05	0.000459	CcSEcCtD
Zalcitabine—Vomiting—Sunitinib—pancreatic cancer	2.22e-05	0.000458	CcSEcCtD
Zalcitabine—Body temperature increased—Gemcitabine—pancreatic cancer	2.21e-05	0.000457	CcSEcCtD
Zalcitabine—Neutropenia—Epirubicin—pancreatic cancer	2.2e-05	0.000455	CcSEcCtD
Zalcitabine—Dysuria—Epirubicin—pancreatic cancer	2.2e-05	0.000455	CcSEcCtD
Zalcitabine—Rash—Sunitinib—pancreatic cancer	2.2e-05	0.000454	CcSEcCtD
Zalcitabine—Dermatitis—Sunitinib—pancreatic cancer	2.2e-05	0.000454	CcSEcCtD
Zalcitabine—Abdominal distension—Doxorubicin—pancreatic cancer	2.19e-05	0.000453	CcSEcCtD
Zalcitabine—Urticaria—Fluorouracil—pancreatic cancer	2.18e-05	0.000451	CcSEcCtD
Zalcitabine—Headache—Sunitinib—pancreatic cancer	2.18e-05	0.000451	CcSEcCtD
Zalcitabine—Syncope—Docetaxel—pancreatic cancer	2.18e-05	0.00045	CcSEcCtD
Zalcitabine—Dysphagia—Doxorubicin—pancreatic cancer	2.18e-05	0.00045	CcSEcCtD
Zalcitabine—Leukopenia—Docetaxel—pancreatic cancer	2.18e-05	0.00045	CcSEcCtD
Zalcitabine—Pollakiuria—Epirubicin—pancreatic cancer	2.17e-05	0.000449	CcSEcCtD
Zalcitabine—Body temperature increased—Fluorouracil—pancreatic cancer	2.17e-05	0.000449	CcSEcCtD
Zalcitabine—Eosinophilia—Doxorubicin—pancreatic cancer	2.16e-05	0.000445	CcSEcCtD
Zalcitabine—Palpitations—Docetaxel—pancreatic cancer	2.15e-05	0.000444	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Epirubicin—pancreatic cancer	2.15e-05	0.000444	CcSEcCtD
Zalcitabine—Loss of consciousness—Docetaxel—pancreatic cancer	2.14e-05	0.000441	CcSEcCtD
Zalcitabine—Pancreatitis—Doxorubicin—pancreatic cancer	2.14e-05	0.000441	CcSEcCtD
Zalcitabine—Weight decreased—Epirubicin—pancreatic cancer	2.13e-05	0.00044	CcSEcCtD
Zalcitabine—Hyperglycaemia—Epirubicin—pancreatic cancer	2.12e-05	0.000439	CcSEcCtD
Zalcitabine—Cough—Docetaxel—pancreatic cancer	2.12e-05	0.000438	CcSEcCtD
Zalcitabine—Hypersensitivity—Irinotecan—pancreatic cancer	2.12e-05	0.000437	CcSEcCtD
Zalcitabine—Convulsion—Docetaxel—pancreatic cancer	2.11e-05	0.000435	CcSEcCtD
Zalcitabine—Hypertension—Docetaxel—pancreatic cancer	2.1e-05	0.000434	CcSEcCtD
Zalcitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	2.1e-05	0.00187	CbGpPWpGaD
Zalcitabine—Myalgia—Docetaxel—pancreatic cancer	2.07e-05	0.000428	CcSEcCtD
Zalcitabine—Arthralgia—Docetaxel—pancreatic cancer	2.07e-05	0.000428	CcSEcCtD
Zalcitabine—Asthenia—Irinotecan—pancreatic cancer	2.06e-05	0.000425	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Epirubicin—pancreatic cancer	2.06e-05	0.000425	CcSEcCtD
Zalcitabine—Jaundice—Epirubicin—pancreatic cancer	2.05e-05	0.000423	CcSEcCtD
Zalcitabine—Neutropenia—Doxorubicin—pancreatic cancer	2.04e-05	0.000421	CcSEcCtD
Zalcitabine—Dysuria—Doxorubicin—pancreatic cancer	2.04e-05	0.000421	CcSEcCtD
Zalcitabine—Hypersensitivity—Fluorouracil—pancreatic cancer	2.03e-05	0.000418	CcSEcCtD
Zalcitabine—Dry mouth—Docetaxel—pancreatic cancer	2.02e-05	0.000418	CcSEcCtD
Zalcitabine—Pollakiuria—Doxorubicin—pancreatic cancer	2.01e-05	0.000416	CcSEcCtD
Zalcitabine—Asthenia—Gemcitabine—pancreatic cancer	2.01e-05	0.000414	CcSEcCtD
Zalcitabine—Confusional state—Docetaxel—pancreatic cancer	2e-05	0.000413	CcSEcCtD
Zalcitabine—DCK—Metabolism—PRSS1—pancreatic cancer	2e-05	0.00178	CbGpPWpGaD
Zalcitabine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	1.99e-05	0.000411	CcSEcCtD
Zalcitabine—Oedema—Docetaxel—pancreatic cancer	1.98e-05	0.00041	CcSEcCtD
Zalcitabine—Epistaxis—Epirubicin—pancreatic cancer	1.98e-05	0.000409	CcSEcCtD
Zalcitabine—Pruritus—Gemcitabine—pancreatic cancer	1.98e-05	0.000409	CcSEcCtD
Zalcitabine—Infection—Docetaxel—pancreatic cancer	1.97e-05	0.000407	CcSEcCtD
Zalcitabine—Weight decreased—Doxorubicin—pancreatic cancer	1.97e-05	0.000407	CcSEcCtD
Zalcitabine—Sinusitis—Epirubicin—pancreatic cancer	1.97e-05	0.000407	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—PRSS1—pancreatic cancer	1.97e-05	0.00176	CbGpPWpGaD
Zalcitabine—Hyperglycaemia—Doxorubicin—pancreatic cancer	1.97e-05	0.000406	CcSEcCtD
Zalcitabine—Diarrhoea—Irinotecan—pancreatic cancer	1.96e-05	0.000406	CcSEcCtD
Zalcitabine—Shock—Docetaxel—pancreatic cancer	1.95e-05	0.000403	CcSEcCtD
Zalcitabine—Pruritus—Fluorouracil—pancreatic cancer	1.95e-05	0.000402	CcSEcCtD
Zalcitabine—Thrombocytopenia—Docetaxel—pancreatic cancer	1.94e-05	0.000401	CcSEcCtD
Zalcitabine—Tachycardia—Docetaxel—pancreatic cancer	1.94e-05	0.0004	CcSEcCtD
Zalcitabine—Skin disorder—Docetaxel—pancreatic cancer	1.93e-05	0.000398	CcSEcCtD
Zalcitabine—Diarrhoea—Gemcitabine—pancreatic cancer	1.91e-05	0.000395	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	1.9e-05	0.000393	CcSEcCtD
Zalcitabine—Dizziness—Irinotecan—pancreatic cancer	1.9e-05	0.000392	CcSEcCtD
Zalcitabine—Jaundice—Doxorubicin—pancreatic cancer	1.89e-05	0.000391	CcSEcCtD
Zalcitabine—Anorexia—Docetaxel—pancreatic cancer	1.89e-05	0.000391	CcSEcCtD
Zalcitabine—Rhinitis—Epirubicin—pancreatic cancer	1.89e-05	0.00039	CcSEcCtD
Zalcitabine—Hepatitis—Epirubicin—pancreatic cancer	1.88e-05	0.000389	CcSEcCtD
Zalcitabine—Diarrhoea—Fluorouracil—pancreatic cancer	1.88e-05	0.000389	CcSEcCtD
Zalcitabine—Pharyngitis—Epirubicin—pancreatic cancer	1.87e-05	0.000386	CcSEcCtD
Zalcitabine—Epistaxis—Doxorubicin—pancreatic cancer	1.83e-05	0.000378	CcSEcCtD
Zalcitabine—Vomiting—Irinotecan—pancreatic cancer	1.83e-05	0.000377	CcSEcCtD
Zalcitabine—Sinusitis—Doxorubicin—pancreatic cancer	1.82e-05	0.000376	CcSEcCtD
Zalcitabine—Dizziness—Fluorouracil—pancreatic cancer	1.82e-05	0.000376	CcSEcCtD
Zalcitabine—Visual impairment—Epirubicin—pancreatic cancer	1.82e-05	0.000375	CcSEcCtD
Zalcitabine—Rash—Irinotecan—pancreatic cancer	1.81e-05	0.000374	CcSEcCtD
Zalcitabine—Dermatitis—Irinotecan—pancreatic cancer	1.81e-05	0.000374	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	1.81e-05	0.000374	CcSEcCtD
Zalcitabine—Headache—Irinotecan—pancreatic cancer	1.8e-05	0.000372	CcSEcCtD
Zalcitabine—Insomnia—Docetaxel—pancreatic cancer	1.8e-05	0.000371	CcSEcCtD
Zalcitabine—Vomiting—Gemcitabine—pancreatic cancer	1.78e-05	0.000367	CcSEcCtD
Zalcitabine—Dyspnoea—Docetaxel—pancreatic cancer	1.77e-05	0.000365	CcSEcCtD
Zalcitabine—Somnolence—Docetaxel—pancreatic cancer	1.76e-05	0.000364	CcSEcCtD
Zalcitabine—Rash—Gemcitabine—pancreatic cancer	1.76e-05	0.000364	CcSEcCtD
Zalcitabine—Dermatitis—Gemcitabine—pancreatic cancer	1.76e-05	0.000364	CcSEcCtD
Zalcitabine—Eye disorder—Epirubicin—pancreatic cancer	1.76e-05	0.000364	CcSEcCtD
Zalcitabine—Tinnitus—Epirubicin—pancreatic cancer	1.76e-05	0.000363	CcSEcCtD
Zalcitabine—Headache—Gemcitabine—pancreatic cancer	1.75e-05	0.000362	CcSEcCtD
Zalcitabine—Flushing—Epirubicin—pancreatic cancer	1.75e-05	0.000361	CcSEcCtD
Zalcitabine—Vomiting—Fluorouracil—pancreatic cancer	1.75e-05	0.000361	CcSEcCtD
Zalcitabine—Rhinitis—Doxorubicin—pancreatic cancer	1.75e-05	0.000361	CcSEcCtD
Zalcitabine—Dyspepsia—Docetaxel—pancreatic cancer	1.75e-05	0.000361	CcSEcCtD
Zalcitabine—Hepatitis—Doxorubicin—pancreatic cancer	1.74e-05	0.00036	CcSEcCtD
Zalcitabine—Rash—Fluorouracil—pancreatic cancer	1.73e-05	0.000358	CcSEcCtD
Zalcitabine—DCK—Metabolism—ARG2—pancreatic cancer	1.73e-05	0.00155	CbGpPWpGaD
Zalcitabine—Dermatitis—Fluorouracil—pancreatic cancer	1.73e-05	0.000358	CcSEcCtD
Zalcitabine—Pharyngitis—Doxorubicin—pancreatic cancer	1.73e-05	0.000357	CcSEcCtD
Zalcitabine—Decreased appetite—Docetaxel—pancreatic cancer	1.73e-05	0.000356	CcSEcCtD
Zalcitabine—Headache—Fluorouracil—pancreatic cancer	1.72e-05	0.000356	CcSEcCtD
Zalcitabine—Fatigue—Docetaxel—pancreatic cancer	1.71e-05	0.000353	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—ARG2—pancreatic cancer	1.71e-05	0.00152	CbGpPWpGaD
Zalcitabine—Pain—Docetaxel—pancreatic cancer	1.7e-05	0.000351	CcSEcCtD
Zalcitabine—Chills—Epirubicin—pancreatic cancer	1.69e-05	0.000349	CcSEcCtD
Zalcitabine—Arrhythmia—Epirubicin—pancreatic cancer	1.68e-05	0.000348	CcSEcCtD
Zalcitabine—Visual impairment—Doxorubicin—pancreatic cancer	1.68e-05	0.000347	CcSEcCtD
Zalcitabine—Alopecia—Epirubicin—pancreatic cancer	1.67e-05	0.000344	CcSEcCtD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.65e-05	0.00147	CbGpPWpGaD
Zalcitabine—Feeling abnormal—Docetaxel—pancreatic cancer	1.64e-05	0.000338	CcSEcCtD
Zalcitabine—Eye disorder—Doxorubicin—pancreatic cancer	1.63e-05	0.000337	CcSEcCtD
Zalcitabine—Tinnitus—Doxorubicin—pancreatic cancer	1.63e-05	0.000336	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Docetaxel—pancreatic cancer	1.62e-05	0.000335	CcSEcCtD
Zalcitabine—Flushing—Doxorubicin—pancreatic cancer	1.62e-05	0.000334	CcSEcCtD
Zalcitabine—Flatulence—Epirubicin—pancreatic cancer	1.62e-05	0.000334	CcSEcCtD
Zalcitabine—Tension—Epirubicin—pancreatic cancer	1.61e-05	0.000332	CcSEcCtD
Zalcitabine—Dysgeusia—Epirubicin—pancreatic cancer	1.61e-05	0.000332	CcSEcCtD
Zalcitabine—Nervousness—Epirubicin—pancreatic cancer	1.59e-05	0.000329	CcSEcCtD
Zalcitabine—Back pain—Epirubicin—pancreatic cancer	1.59e-05	0.000328	CcSEcCtD
Zalcitabine—Muscle spasms—Epirubicin—pancreatic cancer	1.58e-05	0.000326	CcSEcCtD
Zalcitabine—Abdominal pain—Docetaxel—pancreatic cancer	1.57e-05	0.000324	CcSEcCtD
Zalcitabine—Body temperature increased—Docetaxel—pancreatic cancer	1.57e-05	0.000324	CcSEcCtD
Zalcitabine—Chills—Doxorubicin—pancreatic cancer	1.56e-05	0.000323	CcSEcCtD
Zalcitabine—Arrhythmia—Doxorubicin—pancreatic cancer	1.56e-05	0.000322	CcSEcCtD
Zalcitabine—Vision blurred—Epirubicin—pancreatic cancer	1.55e-05	0.000319	CcSEcCtD
Zalcitabine—Alopecia—Doxorubicin—pancreatic cancer	1.54e-05	0.000318	CcSEcCtD
Zalcitabine—Ill-defined disorder—Epirubicin—pancreatic cancer	1.52e-05	0.000314	CcSEcCtD
Zalcitabine—Anaemia—Epirubicin—pancreatic cancer	1.52e-05	0.000313	CcSEcCtD
Zalcitabine—DCK—Metabolism—TYMP—pancreatic cancer	1.52e-05	0.00135	CbGpPWpGaD
Zalcitabine—Agitation—Epirubicin—pancreatic cancer	1.51e-05	0.000311	CcSEcCtD
Zalcitabine—Flatulence—Doxorubicin—pancreatic cancer	1.5e-05	0.000309	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—TYMP—pancreatic cancer	1.49e-05	0.00133	CbGpPWpGaD
Zalcitabine—Tension—Doxorubicin—pancreatic cancer	1.49e-05	0.000308	CcSEcCtD
Zalcitabine—Dysgeusia—Doxorubicin—pancreatic cancer	1.49e-05	0.000307	CcSEcCtD
Zalcitabine—Malaise—Epirubicin—pancreatic cancer	1.48e-05	0.000306	CcSEcCtD
Zalcitabine—Nervousness—Doxorubicin—pancreatic cancer	1.47e-05	0.000304	CcSEcCtD
Zalcitabine—Vertigo—Epirubicin—pancreatic cancer	1.47e-05	0.000304	CcSEcCtD
Zalcitabine—Syncope—Epirubicin—pancreatic cancer	1.47e-05	0.000304	CcSEcCtD
Zalcitabine—Leukopenia—Epirubicin—pancreatic cancer	1.47e-05	0.000303	CcSEcCtD
Zalcitabine—Back pain—Doxorubicin—pancreatic cancer	1.47e-05	0.000303	CcSEcCtD
Zalcitabine—Hypersensitivity—Docetaxel—pancreatic cancer	1.46e-05	0.000302	CcSEcCtD
Zalcitabine—Muscle spasms—Doxorubicin—pancreatic cancer	1.46e-05	0.000301	CcSEcCtD
Zalcitabine—Palpitations—Epirubicin—pancreatic cancer	1.45e-05	0.000299	CcSEcCtD
Zalcitabine—Loss of consciousness—Epirubicin—pancreatic cancer	1.44e-05	0.000298	CcSEcCtD
Zalcitabine—Cough—Epirubicin—pancreatic cancer	1.43e-05	0.000296	CcSEcCtD
Zalcitabine—Vision blurred—Doxorubicin—pancreatic cancer	1.43e-05	0.000295	CcSEcCtD
Zalcitabine—Asthenia—Docetaxel—pancreatic cancer	1.42e-05	0.000294	CcSEcCtD
Zalcitabine—Convulsion—Epirubicin—pancreatic cancer	1.42e-05	0.000294	CcSEcCtD
Zalcitabine—Hypertension—Epirubicin—pancreatic cancer	1.42e-05	0.000293	CcSEcCtD
Zalcitabine—Ill-defined disorder—Doxorubicin—pancreatic cancer	1.41e-05	0.000291	CcSEcCtD
Zalcitabine—Pruritus—Docetaxel—pancreatic cancer	1.4e-05	0.00029	CcSEcCtD
Zalcitabine—Anaemia—Doxorubicin—pancreatic cancer	1.4e-05	0.00029	CcSEcCtD
Zalcitabine—Arthralgia—Epirubicin—pancreatic cancer	1.4e-05	0.000288	CcSEcCtD
Zalcitabine—Myalgia—Epirubicin—pancreatic cancer	1.4e-05	0.000288	CcSEcCtD
Zalcitabine—Agitation—Doxorubicin—pancreatic cancer	1.39e-05	0.000288	CcSEcCtD
Zalcitabine—Anxiety—Epirubicin—pancreatic cancer	1.39e-05	0.000287	CcSEcCtD
Zalcitabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	1.38e-05	0.00123	CbGpPWpGaD
Zalcitabine—Discomfort—Epirubicin—pancreatic cancer	1.38e-05	0.000285	CcSEcCtD
Zalcitabine—Malaise—Doxorubicin—pancreatic cancer	1.37e-05	0.000283	CcSEcCtD
Zalcitabine—Dry mouth—Epirubicin—pancreatic cancer	1.37e-05	0.000282	CcSEcCtD
Zalcitabine—Vertigo—Doxorubicin—pancreatic cancer	1.36e-05	0.000282	CcSEcCtD
Zalcitabine—Syncope—Doxorubicin—pancreatic cancer	1.36e-05	0.000281	CcSEcCtD
Zalcitabine—Leukopenia—Doxorubicin—pancreatic cancer	1.36e-05	0.000281	CcSEcCtD
Zalcitabine—Diarrhoea—Docetaxel—pancreatic cancer	1.36e-05	0.00028	CcSEcCtD
Zalcitabine—Confusional state—Epirubicin—pancreatic cancer	1.35e-05	0.000279	CcSEcCtD
Zalcitabine—Palpitations—Doxorubicin—pancreatic cancer	1.34e-05	0.000277	CcSEcCtD
Zalcitabine—Oedema—Epirubicin—pancreatic cancer	1.34e-05	0.000277	CcSEcCtD
Zalcitabine—Loss of consciousness—Doxorubicin—pancreatic cancer	1.33e-05	0.000276	CcSEcCtD
Zalcitabine—Infection—Epirubicin—pancreatic cancer	1.33e-05	0.000275	CcSEcCtD
Zalcitabine—Cough—Doxorubicin—pancreatic cancer	1.32e-05	0.000274	CcSEcCtD
Zalcitabine—Shock—Epirubicin—pancreatic cancer	1.32e-05	0.000272	CcSEcCtD
Zalcitabine—Convulsion—Doxorubicin—pancreatic cancer	1.32e-05	0.000272	CcSEcCtD
Zalcitabine—Dizziness—Docetaxel—pancreatic cancer	1.31e-05	0.000271	CcSEcCtD
Zalcitabine—Thrombocytopenia—Epirubicin—pancreatic cancer	1.31e-05	0.000271	CcSEcCtD
Zalcitabine—Hypertension—Doxorubicin—pancreatic cancer	1.31e-05	0.000271	CcSEcCtD
Zalcitabine—Tachycardia—Epirubicin—pancreatic cancer	1.31e-05	0.00027	CcSEcCtD
Zalcitabine—Skin disorder—Epirubicin—pancreatic cancer	1.3e-05	0.000269	CcSEcCtD
Zalcitabine—Hyperhidrosis—Epirubicin—pancreatic cancer	1.29e-05	0.000267	CcSEcCtD
Zalcitabine—Arthralgia—Doxorubicin—pancreatic cancer	1.29e-05	0.000267	CcSEcCtD
Zalcitabine—Myalgia—Doxorubicin—pancreatic cancer	1.29e-05	0.000267	CcSEcCtD
Zalcitabine—Anxiety—Doxorubicin—pancreatic cancer	1.29e-05	0.000266	CcSEcCtD
Zalcitabine—Discomfort—Doxorubicin—pancreatic cancer	1.28e-05	0.000264	CcSEcCtD
Zalcitabine—Anorexia—Epirubicin—pancreatic cancer	1.28e-05	0.000264	CcSEcCtD
Zalcitabine—Dry mouth—Doxorubicin—pancreatic cancer	1.26e-05	0.000261	CcSEcCtD
Zalcitabine—Vomiting—Docetaxel—pancreatic cancer	1.26e-05	0.000261	CcSEcCtD
Zalcitabine—Rash—Docetaxel—pancreatic cancer	1.25e-05	0.000258	CcSEcCtD
Zalcitabine—Dermatitis—Docetaxel—pancreatic cancer	1.25e-05	0.000258	CcSEcCtD
Zalcitabine—Confusional state—Doxorubicin—pancreatic cancer	1.25e-05	0.000258	CcSEcCtD
Zalcitabine—Headache—Docetaxel—pancreatic cancer	1.24e-05	0.000257	CcSEcCtD
Zalcitabine—Oedema—Doxorubicin—pancreatic cancer	1.24e-05	0.000256	CcSEcCtD
Zalcitabine—Infection—Doxorubicin—pancreatic cancer	1.23e-05	0.000254	CcSEcCtD
Zalcitabine—DCK—Metabolism—GLP1R—pancreatic cancer	1.22e-05	0.00109	CbGpPWpGaD
Zalcitabine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.22e-05	0.000252	CcSEcCtD
Zalcitabine—Shock—Doxorubicin—pancreatic cancer	1.22e-05	0.000252	CcSEcCtD
Zalcitabine—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.21e-05	0.000251	CcSEcCtD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	1.21e-05	0.00108	CbGpPWpGaD
Zalcitabine—Insomnia—Epirubicin—pancreatic cancer	1.21e-05	0.00025	CcSEcCtD
Zalcitabine—Tachycardia—Doxorubicin—pancreatic cancer	1.21e-05	0.00025	CcSEcCtD
Zalcitabine—Skin disorder—Doxorubicin—pancreatic cancer	1.2e-05	0.000249	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—GLP1R—pancreatic cancer	1.2e-05	0.00107	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—DPYD—pancreatic cancer	1.2e-05	0.00107	CbGpPWpGaD
Zalcitabine—Hyperhidrosis—Doxorubicin—pancreatic cancer	1.2e-05	0.000247	CcSEcCtD
Zalcitabine—Dyspnoea—Epirubicin—pancreatic cancer	1.19e-05	0.000247	CcSEcCtD
Zalcitabine—Somnolence—Epirubicin—pancreatic cancer	1.19e-05	0.000246	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—DPYD—pancreatic cancer	1.18e-05	0.00106	CbGpPWpGaD
Zalcitabine—Anorexia—Doxorubicin—pancreatic cancer	1.18e-05	0.000244	CcSEcCtD
Zalcitabine—Dyspepsia—Epirubicin—pancreatic cancer	1.18e-05	0.000243	CcSEcCtD
Zalcitabine—Decreased appetite—Epirubicin—pancreatic cancer	1.16e-05	0.00024	CcSEcCtD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.16e-05	0.00103	CbGpPWpGaD
Zalcitabine—Fatigue—Epirubicin—pancreatic cancer	1.15e-05	0.000238	CcSEcCtD
Zalcitabine—Pain—Epirubicin—pancreatic cancer	1.14e-05	0.000236	CcSEcCtD
Zalcitabine—DCK—Metabolism—SLC2A2—pancreatic cancer	1.14e-05	0.00102	CbGpPWpGaD
Zalcitabine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.13e-05	0.000233	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—SLC2A2—pancreatic cancer	1.12e-05	0.001	CbGpPWpGaD
Zalcitabine—Insomnia—Doxorubicin—pancreatic cancer	1.12e-05	0.000231	CcSEcCtD
Zalcitabine—Dyspnoea—Doxorubicin—pancreatic cancer	1.1e-05	0.000228	CcSEcCtD
Zalcitabine—Feeling abnormal—Epirubicin—pancreatic cancer	1.1e-05	0.000228	CcSEcCtD
Zalcitabine—Somnolence—Doxorubicin—pancreatic cancer	1.1e-05	0.000227	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.09e-05	0.000226	CcSEcCtD
Zalcitabine—Dyspepsia—Doxorubicin—pancreatic cancer	1.09e-05	0.000225	CcSEcCtD
Zalcitabine—Decreased appetite—Doxorubicin—pancreatic cancer	1.08e-05	0.000222	CcSEcCtD
Zalcitabine—Fatigue—Doxorubicin—pancreatic cancer	1.07e-05	0.000221	CcSEcCtD
Zalcitabine—Urticaria—Epirubicin—pancreatic cancer	1.06e-05	0.00022	CcSEcCtD
Zalcitabine—Pain—Doxorubicin—pancreatic cancer	1.06e-05	0.000219	CcSEcCtD
Zalcitabine—Body temperature increased—Epirubicin—pancreatic cancer	1.06e-05	0.000219	CcSEcCtD
Zalcitabine—Abdominal pain—Epirubicin—pancreatic cancer	1.06e-05	0.000219	CcSEcCtD
Zalcitabine—Feeling abnormal—Doxorubicin—pancreatic cancer	1.02e-05	0.000211	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.01e-05	0.000209	CcSEcCtD
Zalcitabine—Hypersensitivity—Epirubicin—pancreatic cancer	9.86e-06	0.000204	CcSEcCtD
Zalcitabine—Urticaria—Doxorubicin—pancreatic cancer	9.84e-06	0.000203	CcSEcCtD
Zalcitabine—Abdominal pain—Doxorubicin—pancreatic cancer	9.79e-06	0.000202	CcSEcCtD
Zalcitabine—Body temperature increased—Doxorubicin—pancreatic cancer	9.79e-06	0.000202	CcSEcCtD
Zalcitabine—Asthenia—Epirubicin—pancreatic cancer	9.61e-06	0.000198	CcSEcCtD
Zalcitabine—Pruritus—Epirubicin—pancreatic cancer	9.47e-06	0.000196	CcSEcCtD
Zalcitabine—Diarrhoea—Epirubicin—pancreatic cancer	9.16e-06	0.000189	CcSEcCtD
Zalcitabine—Hypersensitivity—Doxorubicin—pancreatic cancer	9.13e-06	0.000189	CcSEcCtD
Zalcitabine—Asthenia—Doxorubicin—pancreatic cancer	8.89e-06	0.000184	CcSEcCtD
Zalcitabine—Dizziness—Epirubicin—pancreatic cancer	8.85e-06	0.000183	CcSEcCtD
Zalcitabine—DCK—Metabolism—CD44—pancreatic cancer	8.83e-06	0.000788	CbGpPWpGaD
Zalcitabine—Pruritus—Doxorubicin—pancreatic cancer	8.76e-06	0.000181	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—CD44—pancreatic cancer	8.7e-06	0.000776	CbGpPWpGaD
Zalcitabine—Vomiting—Epirubicin—pancreatic cancer	8.51e-06	0.000176	CcSEcCtD
Zalcitabine—Diarrhoea—Doxorubicin—pancreatic cancer	8.48e-06	0.000175	CcSEcCtD
Zalcitabine—DCK—Metabolism—GCG—pancreatic cancer	8.47e-06	0.000755	CbGpPWpGaD
Zalcitabine—Rash—Epirubicin—pancreatic cancer	8.44e-06	0.000174	CcSEcCtD
Zalcitabine—Dermatitis—Epirubicin—pancreatic cancer	8.43e-06	0.000174	CcSEcCtD
Zalcitabine—Headache—Epirubicin—pancreatic cancer	8.39e-06	0.000173	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—GCG—pancreatic cancer	8.34e-06	0.000744	CbGpPWpGaD
Zalcitabine—Dizziness—Doxorubicin—pancreatic cancer	8.19e-06	0.000169	CcSEcCtD
Zalcitabine—DCK—Metabolism—STK11—pancreatic cancer	7.96e-06	0.00071	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PRSS1—pancreatic cancer	7.93e-06	0.000707	CbGpPWpGaD
Zalcitabine—Vomiting—Doxorubicin—pancreatic cancer	7.88e-06	0.000163	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—STK11—pancreatic cancer	7.84e-06	0.000699	CbGpPWpGaD
Zalcitabine—Rash—Doxorubicin—pancreatic cancer	7.81e-06	0.000161	CcSEcCtD
Zalcitabine—Dermatitis—Doxorubicin—pancreatic cancer	7.8e-06	0.000161	CcSEcCtD
Zalcitabine—Headache—Doxorubicin—pancreatic cancer	7.76e-06	0.00016	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—ARG2—pancreatic cancer	6.88e-06	0.000613	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—TYMS—pancreatic cancer	6.85e-06	0.000611	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—TYMS—pancreatic cancer	6.74e-06	0.000601	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TYMP—pancreatic cancer	6.01e-06	0.000536	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PRSS1—pancreatic cancer	5.73e-06	0.000511	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—APOE—pancreatic cancer	5.57e-06	0.000497	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—APOE—pancreatic cancer	5.48e-06	0.000489	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CG—pancreatic cancer	5.03e-06	0.000448	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ARG2—pancreatic cancer	4.97e-06	0.000443	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CG—pancreatic cancer	4.95e-06	0.000441	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PPARG—pancreatic cancer	4.85e-06	0.000433	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GLP1R—pancreatic cancer	4.84e-06	0.000432	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PPARG—pancreatic cancer	4.78e-06	0.000426	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—DPYD—pancreatic cancer	4.77e-06	0.000425	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SLC2A2—pancreatic cancer	4.52e-06	0.000403	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CD—pancreatic cancer	4.42e-06	0.000394	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CD—pancreatic cancer	4.35e-06	0.000388	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TYMP—pancreatic cancer	4.34e-06	0.000388	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	4.08e-06	0.000364	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PRSS1—pancreatic cancer	4.04e-06	0.00036	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CB—pancreatic cancer	3.85e-06	0.000343	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—pancreatic cancer	3.82e-06	0.00034	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CB—pancreatic cancer	3.79e-06	0.000338	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—pancreatic cancer	3.76e-06	0.000335	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.53e-06	0.000315	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ARG2—pancreatic cancer	3.5e-06	0.000313	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CD44—pancreatic cancer	3.5e-06	0.000312	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GLP1R—pancreatic cancer	3.5e-06	0.000312	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—DPYD—pancreatic cancer	3.45e-06	0.000307	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GCG—pancreatic cancer	3.36e-06	0.0003	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTEN—pancreatic cancer	3.33e-06	0.000297	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTEN—pancreatic cancer	3.28e-06	0.000292	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	3.27e-06	0.000292	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—STK11—pancreatic cancer	3.16e-06	0.000282	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TYMP—pancreatic cancer	3.09e-06	0.000276	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TYMP—pancreatic cancer	3.06e-06	0.000273	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TYMS—pancreatic cancer	2.72e-06	0.000242	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.67e-06	0.000238	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CD44—pancreatic cancer	2.53e-06	0.000226	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.53e-06	0.000225	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.49e-06	0.000222	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GLP1R—pancreatic cancer	2.47e-06	0.00022	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.45e-06	0.000219	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—DPYD—pancreatic cancer	2.43e-06	0.000217	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GCG—pancreatic cancer	2.43e-06	0.000217	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CA—pancreatic cancer	2.35e-06	0.000209	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.32e-06	0.000207	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CA—pancreatic cancer	2.31e-06	0.000206	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.31e-06	0.000206	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	2.3e-06	0.000206	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—STK11—pancreatic cancer	2.28e-06	0.000204	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.28e-06	0.000203	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOE—pancreatic cancer	2.21e-06	0.000197	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.2e-06	0.000196	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.02e-06	0.00018	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.01e-06	0.000179	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	1.99e-06	0.000178	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.96e-06	0.000175	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARG—pancreatic cancer	1.92e-06	0.000172	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—pancreatic cancer	1.92e-06	0.000171	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—pancreatic cancer	1.89e-06	0.000168	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.8e-06	0.000161	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CD44—pancreatic cancer	1.78e-06	0.000159	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	1.75e-06	0.000156	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.75e-06	0.000156	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.73e-06	0.000154	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.73e-06	0.000154	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GCG—pancreatic cancer	1.71e-06	0.000153	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.63e-06	0.000145	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.62e-06	0.000145	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—STK11—pancreatic cancer	1.61e-06	0.000144	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.6e-06	0.000143	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOE—pancreatic cancer	1.6e-06	0.000142	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	1.53e-06	0.000136	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.52e-06	0.000136	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—pancreatic cancer	1.51e-06	0.000135	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.51e-06	0.000135	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	1.44e-06	0.000129	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.4e-06	0.000125	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARG—pancreatic cancer	1.39e-06	0.000124	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TYMS—pancreatic cancer	1.38e-06	0.000123	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTEN—pancreatic cancer	1.32e-06	0.000118	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	1.27e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.18e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.14e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.13e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOE—pancreatic cancer	1.13e-06	0.0001	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	1.1e-06	9.85e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—pancreatic cancer	1.09e-06	9.76e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.07e-06	9.5e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.06e-06	9.46e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.02e-06	9.14e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.02e-06	9.06e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARG—pancreatic cancer	9.89e-07	8.82e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARG—pancreatic cancer	9.8e-07	8.75e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTEN—pancreatic cancer	9.54e-07	8.51e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	9.31e-07	8.31e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TYMS—pancreatic cancer	9.13e-07	8.14e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	9.01e-07	8.03e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	8.93e-07	7.97e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	7.85e-07	7e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	7.78e-07	6.94e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	7.78e-07	6.94e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	7.71e-07	6.88e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—pancreatic cancer	7.61e-07	6.79e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOE—pancreatic cancer	7.42e-07	6.62e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTEN—pancreatic cancer	6.78e-07	6.05e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	6.73e-07	6e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTEN—pancreatic cancer	6.73e-07	6e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	6.7e-07	5.98e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARG—pancreatic cancer	6.47e-07	5.77e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.89e-07	5.25e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—pancreatic cancer	5.5e-07	4.9e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	5.13e-07	4.58e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	5.09e-07	4.54e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.79e-07	4.27e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	4.74e-07	4.23e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.44e-07	3.96e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.91e-07	3.49e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—pancreatic cancer	3.88e-07	3.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.13e-07	2.79e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.56e-07	2.28e-05	CbGpPWpGaD
